This official launch, taking place online on 2 December 2021, marks the publication of the report of the EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. This prestigious event is a culmination…
Join patients advocates, healthcare specialists, and other experts for an engaging discussion around the status of health literacy, with a special focus on literacy related to liver health. Health literacy has gained considerable attention globally in recent years. Health literacy…
Under the patronage of the Slovenian presidency of the Council of the European Union, the European Association for Study of the Liver (EASL) and the European Liver Patients’ Association (ELPA) are organising an advocacy event with the support of: University…
NAFLD is the leading cause of chronic liver disease, along with higher risk of diabetes, cardiovascular disease, and cancer, and thus a major public health challenge. NAFLD represents a therapeutic area of as yet unmet clinical lead. This 4th iteration…
This episode of EASL’s webcast series on COVID-19 and the liver examines the impact of the virus on patients with obesity and fatty liver disease. The panel of experts comprises Professor Sven Francque, Professor Nalu Navarro-Alvarez, Professor Luca Busetto and…
